Multiparameter assessment of exercise capacity in patients with arterial hypertension
Małgorzata Kurpaska1, Paweł Krzesiński1, Grzegorz Gielerak1
1a Department of Cardiology and Internal Medicine, Military Institute of Medicine , Warsaw , Poland.
Insights
Hypertension impacts exercise capacity. Hemodynamic measures from impedance cardiography correlate with exercise capacity tests, showing its clinical utility for assessing cardiovascular response to exercise.
Area of Science:
- Cardiology
- Exercise Physiology
Background:
- Arterial hypertension (AH) is a risk factor for heart failure.
- Assessing exercise capacity is crucial for managing hypertensive patients.
Purpose of the Study:
- To evaluate the relationship between exercise capacity parameters (6-minute walk test and cardiopulmonary exercise test) and hemodynamic assessments (impedance cardiography) in patients with AH.
Main Methods:
- 98 hypertensive patients underwent exercise testing (CPET, 6MWT) and hemodynamic monitoring (ICG).
- Evaluated correlations between oxygen uptake (VO2), heart rate (HR), stroke volume (SV), and cardiac output (CO) at rest, anaerobic threshold, and peak exercise.
Main Results:
- A significant proportion of patients had reduced exercise capacity.
- Clinically relevant correlations were found between VO2 and hemodynamic parameters (HR, CO) at rest, AT, and peak exercise.
- Changes in VO2 during exercise correlated strongly with changes in HR, SV, and CO, especially in patients with lower peak VO2.
Conclusions:
- Hemodynamic parameters measured by impedance cardiography correlate significantly with exercise capacity.
- Impedance cardiography is a reliable tool for evaluating the cardiovascular system's response to exercise in hypertensive individuals.
Abstract:
Introduction: Arterial hypertension (AH) can lead to the development of heart failure. Aim: Evaluating the relationship between parameters of exercise capacity assessed via a six-minute walk test (6MWT) and cardiopulmonary exercise test (CPET), with a hemodynamic assessment via impedance cardiography (ICG), in patients with AH. Methods: Exercise capacity was assessed in 98 hypertensive patients (54.5 ± 8.2 years) by means of oxygen uptake (VO2) get from CPET, 6MWT distance (6MWTd) and hemodynamic parameters measured by ICG: heart rate (HR), stroke volume (SV), cardiac output (CO). Correlations between these parameters at rest, at anaerobic threshold (AT) and at peak of exercise as well as their changes (Δpeak-rest, Δpeak-AT, ΔAT-rest) were evaulated. Results: A large proportion of patients exhibited reduced exercise capacity, with 45.9% not reaching 80% of predicted peak VO2 and 43.9% not reaching predicted 6MWTd. Clinically relevant correlations were noted between the absolute peak values and AT values of VO2 vs HR and VO2 vs CO. Furthermore ΔVO2(peak-AT) correlated with ΔHR(peak-AT), ΔCO(peak-AT) and ΔSV(peak-AT); ΔVO2(peak-rest) with ΔHR(peak-rest) and ΔCO(peak-rest); ΔVO2(AT-rest) with ΔHR(AT-rest) and ΔCO(AT-rest). Stronger correlations between changes in the evaluated parameters were demonstrated in the subgroup of subjects with peak VO2 < 80% of the predicted value; particularly ΔVO2(peak-AT) correlated with ΔSV(peak-AT) and ΔCO(peak-AT). Conclusions: The hemodynamic parameters show significant correlations with more measures of cardiovascular capacity of proven clinical utility. Impedance cardiography is a reliable method for assessing the cardiovascular response to exercise.
More Related Videos
08:44Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
07:38Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Lung Capacity
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Design Example: Analyzing Capacity Contours for Flood Risk Assessment
